Logo

Bayer Healthcare Expands License for Genedata's Software

Nov 03, 2008
NEW YORK (GenomeWeb News) – Bayer Healthcare has expanded a ten-year license agreement for Genedata’s software to include all of Bayer Schering Pharma’s drug research sites, Genedata said today.
 
The global agreement builds on a relationship dating back to 1999 and expands a renewed agreement from 2006 that gave Bayer Schering access to Genedata’s Phylosopher and Expressionist software at sites in the US and in Germany.
 
Genedata said it also will support integration services and will provide interfaces to existing research logistics infrastructure such as lab technologies and related IT systems.
 
Phylosopher is used to manage biological target information and Expressionist is used in quality control of gene expression data, for statistical analysis, and for processing data from high-throughput studies.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.